Ulland Investment Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Ulland Investment Advisors's RGEN Position: Q1 2024 in Review
Ulland Investment Advisors sold out of Repligen (RGEN) in Q1 2024, closing a stake of 41 shares — an estimated $7K sold.
Ulland Investment Advisors first reported a position in RGEN in Q4 2021 and held it in 9 quarters. The position peaked at $11K in Q4 2021. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.
- Ulland Investment Advisors reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
- Ulland Investment Advisors sold 41 Repligen shares in Q1 2024, an estimated $7K.
- Ulland Investment Advisors first reported a position in Repligen in Q4 2021 and held it in 9 quarters.
- Ulland Investment Advisors's Repligen position peaked at $11K in Q4 2021.
- 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.
Based on Ulland Investment Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.